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Novel Photodynamic Therapy Agents: Biochemical Analysis
An Honors Thesis submitted in partial fulfillment of the requirements for Honors in the
Chemistry Department

By
Eboni D. Pullen
Under the mentorship of Dr. Michele McGibony

ABSTRACT
Bioinorganic photochemistry is a rapidly advancing research area in the field of
bioinorganic chemistry. This project seeks to build upon the growing field by
synthesizing and analyzing new photodynamic therapy (PDT) agents. There are three
major generations of PDT agents. The first generation consists of chemically modified
natural hematoporphyrins, which are not of great interest in the phototherapeutic field
due to their low distinguishability between tumor cells and healthy cells, and extended
skin photosensitivity in patients. The second generation consists of organic dyes,
aromatic hydrocarbons, polypyrolics complexes, and semi-conductors, but is also not of
much interest due to the same issues as the first generation. The third generation of PDT
agents, the focus of this project, consists of tetrapyrroles and porphyrins. Porphyrins are
essential because they can accept many different metals in their core, which result in
changes of its properties for both therapeutic and photodynamic purposes. Porphyrins are
also found in other biological molecules such as heme, chlorophyll, and vitamin B12.
This project specifically focuses on metalloporphyrins encompassing manganese, and if
these porphyrins display a high DNA cleavage rate they could be used in place of the first
and second generation PDT agents. MnTDCLPP, MnTTFMPP, and MnTECP are the
specific metalloporphyrins being analyzed in this project.
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Introduction
Photodynamic therapy, also called photochemotherapy, is used in many areas of
medicine to shrink tumors, treat skin diseases, and deactivate viruses, such as HIV-1 and
HSV-1.4 The use of light for medicinal purposes has been studied for a long time, and its
role as a warmer and anti-depressant has been known since ancient times.1 However,
understanding the role of light in biological processes and chemical reactions has become
a growing field in the area of bioinorganic chemistry. All of the mechanisms involved in
tumor destruction by photodynamic therapy are not yet known, but the general process of
photodynamic therapy is the conversion of light energy to chemical energy through a
photosensitizer. The sensitizer is a dye that is activated when exposed to light with the
proper wavelength for the sensitizer to absorb.3 When the photosensitizer reacts with
molecular oxygen in the presence of the light an oxygenated product that is detrimental to
the cell is the result.3 Most photosensitizers are naturally occurring or a chemical
modification of naturally occurring biological compounds. Photosensitizers typically
contain a tetrapyrrole center, which is the part of the molecule that is sensitive to the light
and is activated. The ideal photosensitizer for photodynamic therapy can act as a catalyst,
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is chemically stable, is retained in tumor cells longer than in normal cells, has high
absorption at wavelengths from 650-800nm, and has low dark toxicity so that the
photosensitizer is not activated until exposed to the treatment laser.2 Most
photosensitizers are retained in both healthy cells and tumor cells and have maximum
absorption at wavelengths shorter than the therapeutic window of 650-800nm (Figure 1).2
As a result, photodynamic therapy agents are usually restricted to skin diseases and
surface level tumors because the laser does not penetrate further than one centimeter into
tissue. The longer the wavelength the deeper the laser penetrates into the tissue.
Depending on the type of tumor, the tissue can transmit or scatter the light differently
(Figure 2), and light in the phototherapeutic window can penetrate 50-200% deeper than
light below that window.1

Figure 1: Spectral analysis of biological compounds and the therapeutic window 1
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Figure 2: Visual of light transmittance, refraction, and reflection by tissue 1
Photodynamic therapy works by first injecting the patient with the agent to get it
into the blood stream. Mice studies have shown that about 1% of the photosensitizer dose
is retained in the blood stream after 24 hour, and that 35% can remain in the body after
192 hours.3 The tumor site is then exposed to the laser with the wavelength that
corresponds to the photosensitizer’s maximum absorption. In photodynamic therapy the
photosensitizer goes from its ground state to its first excited state upon absorption of the
light.1 The excited compound is then converted to its excited triplet state through
intersystem crossing. In the excited triplet state it can undergo further chemical reactions
to produce a radical intermediate and reactive singlet oxygen.1 There are three major
modes of attack of photodynamic therapy. The first is direct cell death in the form of
apoptosis, which results from the toxic form of the oxygen that is released. Photodynamic
therapy can directly induce apoptosis without the signal transduction processes that are
sometimes missing in tumor cells.4 The second is indirect cell death in which the oxygen
destroys blood vessels needed to supply the cells with nutrients. The final mode of attack
is cell death from immune system response such as inflammation.1
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hree different generations of photodynamic therapy (PDT) agents.
There are also three
The first generation consists of chemically modified natural hematoporphyrins.1 This
generation is not of much interest in the field due to poor distinguishability
ability between
tumor cells and healthy cells and elevated skin photosensitivity in patients. Doctors
recommend patients stay indoors away from any direct form of light, and this skin
photosensitivity can last up to three months. The second generation of PDT agents
age
consists off organic dyes such as rose bbengal and methylene blue, aromatic
atic hydrocarbons
such as naphthalenes
lenes and quinines, polyprolic complexes, and semiconductors.1 The
second generation is not of much interest due to the same iss
issues
ues as the first;
photosensitivity
osensitivity is tremendous due to the cconjugated ring structures.

Figure 3: Hematoporphyrin and rose bengal 5, 6
The third generation of PDT agents, the focus of this project, consists of
metalloporphyrins which contain a tetrapyrrole center.1 Tetrapyrroles possess a 1616
membered conjugated carbon ring and 18 π electrons. They are found in many natural
bioorganic compounds such as hemoglobin, chlorophyll, and vitamin B12. Tetrapyrroles
are important because they can accept many different metal io
ions into its core to alter its
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properties for photodynamic purposes. These metal ions make the compound unique and
specific to different photodynamic treatments.
The porphyrins that were studied in this research project were manganese inserted
metalloporphyrins named, MnTDCLPP, MnTTFMPP, and MnTECP (Figure 4). It is
known that molecular oxygen can react with catalytic amounts of oxidation-reduction
active metal ions to produce a radical capable of cleaving DNA.2 Therefore, the potential
of these compounds as photodynamic therapy agents can be assessed by how well they
cleave DNA when activated with a laser. DNA cleavage can be analyzed using DNA Gel
Electrophoresis, and the compounds can be studied using UV-Visible Spectroscopy.
Recent work in this laboratory utilizing calf thymus DNA indicated that all three
manganese metalloporphyrins could cleave DNA, but the amount of cleavage is difficult
to ascertain due to the smearing in the gels.7,8 Due to these results, our work focused on
plasmids which are much smaller and easier to visualized via gel electrophoresis.
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Mn

Figure 4: Manganese inserted metalloporphyrins MnTDCLPP (top left), MnTTFMPP
(top right), and MnTECP (bottom middle)9, 10
Experimental/Methods
Gel Preparation
All of the gel electrophoresis analyses were performed using a 0.7% agarose
(Sigma) which was prepared with 0.5XTris-acetate-EDTA (TAE) buffer. The gels were
run at 125 volts for approximately 1 hour in a Fisher brand unit and they were stained
using Edvotek InstaStain Ethidium Bromide Sheets for approximately 10 min. The gels
were photographed under UV light via a UVP Digital Imaging System to visually assess
the DNA for the appearance of cleavage.
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Preparation of DNA Plasmids
A 50ng/µL solution of DNA plasmid (pBR322 or pUC19 from Biolabs) was
prepared by adding 2µL of 1000µg/mL stock solution to 38µL of 0.5XTAE. Varying
amounts of 50ng/µL DNA plasmid (4-16µL) were further diluted to 50µL using
0.5XTAE.
Preparation of Metalloporphyrins
The metalloporphyrins that were used in this experiment (MnTDCLPP,
MnTTFMPP, and MnTECP) were synthesized by Dr. Cynthia P. Tidwell’s laboratory at
Montevallo University in Montevallo, Alabama. The stock solution of 3.175x10-3M
MnTDCLPP was diluted to 3.175x10-4M, the stock solution of 1.99x10-3M MnTTFMPP
was diluted to 1.53x10-4M, and the stock solution of MnTECP was prepared by adding
4mg MnTECP to 11.5mL DMF. All dilutions were prepared with
Dimethylformamide (DMF) as solvent.
DNA Control
As a control, all DNA plasmids were exposed to the laser without any
photodynamic therapy agents. These samples were prepared with 50µL of 5.0ng/µL
pBR322 or pUC19. The DNA was exposed to the Coherent Innova 90C Argon Laser set
at 488nm, 10.0A, and 0.07W. Samples were taken after 0, 10, 30, 60, and 90 minutes of
exposure. Exactly 10µL aliquots were taken and prepared for gel electrophoresis with
0.7% agarose in 0.5XTAE buffer.
Porphyrin Control
The effects of white light (400-800nm) and laser light (488nm) on each of the
metalloporphyrins were assessed by preparing 50µL samples of the metalloporphyrin
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solutions (3.175x10-4M MnTDCLPP, 1.53x10-4M MnTTFMPP, and 1.793x10-1mg/mL
MnTECP) and placing them on a white light apparatus (Figure 5). Shimadzu UV 1601
was used to take a UV spectrum of the metalloporphyrins after various amounts (5, 15,
30, and 60 minutes) of light exposure and the spectra were analyzed. The apparatus
consisted of a 150 watt white light bulb positioned under a pyrex dish that contained
water at 30 C. A glass sheet sat on top of the pyrex dish and held the microtiter plate
containing the metalloporphyrin samples.

Figure 5: White light apparatus
For the Argon laser setup, the samples were placed in either a microtiter plate or a
microfuge tube in direct path of the laser light. The heat generated from the laser is not a
concern and therefore a cooling system is not necessary.
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Figure 6: The 488 nm argon laser apparatus. As light was emitted from the laser a mirror
reflected the laser at a 90

angle toward the tripod ring stand were the eppendorf tubes

containing the sample were placed. The samples had to be activated one at a time.
DNA Cleavage Experiments
The minimum amount of metalloporphyrin and laser activation time needed to
cleave the DNA was assessed. The optimization began by combining arbitrary amounts of
plasmids and porphyrin and diluting the samples to 45µL using 0.5XTAE. The chosen
amounts were 5µL of 50ng/µL DNA and 10µL of metalloporphyrins solutions (3.175x10-
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M MnTDCLPP, 1.53x10-4M MnTTFMPP, and 1.793x10-1mg/mL MnTECP). A control

was also prepared with 10µL of 0.5XTAE in place of the metalloporphyrin solution. The
samples were exposed to a 488nm laser for 30 minutes to analyze the effects of the
activated metalloporphyrin on the DNA. If the DNA showed evidence of cleavage after
30 minutes, then the laser activation time was decreased until no cleavage was evident.
This was accomplished by taking 10µL aliquots of the samples on the laser apparatus in
3-5 minute intervals and analyzing them with 0.7% agarose gel electrophoresis. If the
DNA continued to show signs of cleavage, even after minute amounts of laser activation
time, then the metalloporphyrin concentration was decreased until the difference in DNA
cleavage could be visualized at varying amounts of laser activation.
Data and Results

Figure 7: Varying amounts of 50ng/µL pBR322 were diluted to 50µL samples using
0.5XTAE and analyzed using gel electrophoresis.
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Figure 8: A 50µL sample of 5.0ng/µLpBR322 was exposed to a 488nm laser set at 10.0A
and 0.07W for 90 minutes. Exactly 10µL aliquots of the sample were taken at 0, 10, 30,
60, and 90 minutes, and analyzed using gel electrophoresis.
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Figure 9: Exactly 50µL samples of the metalloporphyrin solutions were placed on a white
light apparatus and a UV Spectrum of the metalloporphyrins was analyzed before and
after activation with the white light.
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Figure 10: Samples were prepared by combining 5µL of 50ng/µL pBR322, 10µL of
metalloporphyrin stock solution, and 50µL 0.5XTAE, and then exposed to 488nm laser
for 30 minutes. DNA cleavage was assessed using 0.7% agarose gel electrophoresis.

Figure 11: Samples were prepared by combining 5µL of 50ng/µL pBR322, 10µL of
metalloporphyrin stock solution, and 35µL of 0.5XTAE, and then exposed to 488nm laser
for 10, 15, and 20 minutes. DNA cleaveage was assessed using 0.7% agarose gel
electrophoresis.
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(a)

(b)
Figure 12: (a) Samples containing 5.556ng/µL pBR322 and varying concentrations of
each metalloporphyrin were exposed to a 488nm laser for 3, 6, and 9 minutes. The DNA
cleavage by the porphyrin was assessed using 0.7% agarose gel electrophoresis. (b) The
metalloporphyrin concentration was decreased while the plasmid concentration and laser
activation time remained constant to further assess its effects on DNA cleavage.
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MnTDCLPP
(nmol/µL)

3 minutes of laser
activation

6 minutes of laser
activation

9 minutes of laser
activation

1.59

Complete Cleavage

Complete Cleavage

Complete Cleavage

1.27

Partial Cleavage

Partial Cleavage

Partial Cleavage

0.95

No Cleavage

No Cleavage

No Cleavage

0.64

No Cleavage

No Cleavage

No Cleavage

0.32

No Cleavage

No Cleavage

No Cleavage

Table 1: Visual determination of DNA cleavage using DNA Gel Electrophoresis and a
UV light box when various amounts of MnTDCLPP and laser activation time were
combined with 5.556ng/µL pBR322
MnTTFMPP
(nmol/µL)

3 minutes of laser
activation

6 minutes of laser
activation

9 minutes of laser
activation

0.77

Complete Cleavage

Complete Cleavage

Complete Cleavage

0.62

Complete Cleavage

Complete Cleavage

Complete Cleavage

0.46

Complete Cleavage

Complete Cleavage

Complete Cleavage

0.31

Partial Cleavage

Complete Cleavage

Complete Cleavage

0.15

No Cleavage

No Cleavage

No Cleavage

Table 2: Visual determination of DNA cleavage using DNA Gel Electrophoresis and UV
light box when various amounts of MnTTFMPP and laser activation time were combined
with 5.556ng/µL pBR322
Discussion/Conclusion
The first objective of this research project was to determine the minimum amount
of plasmid (pBR322) needed to visualize a band in a 0.7% agarose gel. As shown in
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Figure 7, when 4µL of 50ng/µL of pBR322 was diluted to 50µL a band was slightly
visible. This indicates that a plasmid concentration of at least 4ng/µL is necessary to
visualize a band. Once the plasmid concentration was optimized, control experiments
were performed to ensure that the laser did not damage the DNA and that white light did
not activate the metalloporphyrins. Figure 8 demonstrates that the optimum amount of
plasmid (5ng/µL) was not degraded by the 488nm laser for up to 90 minutes of laser
exposure. The control band that had not been exposed to laser was equal in size to all
other bands that were exposed to the laser for various lengths of time. Majority of the
experiments require less than 30 minutes of laser activation, so the 90 minute control
window made certain that there would be no damage to the DNA during our experiments.
The next control experiment involved the effects of white light on the metalloporphyrins.
The UV spectra of the metalloporphyrins were assessed before and after exposure to
white light via the white light apparatus (Figure 5). Figure 9 illustrates the UV spectra of
MnTTFMPP and MnTECP before and after white light activation. These spectra are
almost identical indicating no activation or conformation of the compounds by the white
light. With the knowledge that the laser will not degrade the DNA and that the white light
will not activate the metalloporphyrins, the primary objective of this research project
could be studied.
The purpose of this research project was to discovering the optimum
concentrations of metalloporphyrins and laser exposure time needed to cleave our sample
of DNA. Figure 10 demonstrates that when the arbitrary amounts of plasmid (5µL of
50ng/µL pBR322) and metalloporphyrins (10µL of 3.175x10-4M MnTDCLPP, 1.53x104

M MnTTFMPP, or 1.793x10-1mg/mL MnTECP) were exposed to the 488nm laser for 30
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minutes, the DNA was cleaved in the presence of MnTDCLPP and MnTTFMPP, but not
in the presence of MnTECP. Because 38.64 ng/µL of MnTECP was not able to cleave the
DNA sample after 30 minutes of laser activation the focus shifted to MnTDCLPP and
MnTTFMPP. The laser activation time was steadily decreased, and Figure 11 shows that
our porphyrin concentration continued to cleave the DNA sample after just 10 minutes of
laser activation. The next step was to decrease the metalloporphyrin concentration and
assess DNA cleavage when laser activation was less than ten minutes. The gels from
these experiments can be visualized in Figure 12; the tabulated analyses for DNA
cleavage at varying metalloporphyrin concentrations and laser activation can be seen in
Tables 1 and 2. The information in Table 1 leads to the conclusion that the optimum
conditions to cleave 5.556ng/µL pBR322 using MnTDCLPP is 1.59nmol/µL and 3
minutes of laser activation. Table 2 asserts that the optimum conditions to cleave the
DNA sample using MnTTFMPP is 0.31nmol/µL and 3 minutes of laser activation.
According to these results, MnTTFMPP cleaves DNA with the smallest concentration
and 3 minutes is optimum laser activation time. The high-valent oxo-manganese
porphyrin seems promising as a likely intermediate in DNA cleavage. Future work on this
project includes the analysis of the type of DNA cleavage using HPLC, the activation of
our metalloporphyrins using transilluminator at 312 nm, visible light at 532nm, and HeNe laser at 632.8nm, and the analysis of DNA cleavage with other metalloporphyrins
such as CuTECP.
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